Consortium News
May 2011
California ponders cell-banking venture
Standfirst
State agency grapples with technical and ethical challenges.
New drug targets raise hopes for hepatitis C cure
Standfirst
As the first targeted therapies edge towards regulatory approval, attention turns to the next drugs in line.
Gut study divides people into three types
Standfirst
Bacterial populations fall into three distinct classes that could help to personalize medicine.
Cancer theory faces doubts
Standfirst
A leading explanation for how disease migrates falls short on clinical evidence.
US budget a taste of battles to come
Standfirst
Deal leaves science agencies with less but avoids deep cuts.